NYSE is lowering fees for companies with little to no revenue, a typical characteristic of early biotech firms. Biotechs historically have mostly listed on Nasdaq, in part because of its cheaper fees.
German and U.S. government bond yields fall on gloomy outlook Stocks on Wall Street were set to slide Thursday and U.S. government bond yields reached a 52-week low as disappointing economic data and over
(Reuters) - Stock futures for Canada's main equity index fell on Thursday, tracking losses in global stocks over fears that the Sino-U.S. trade spat was fast developing into a technology cold war. June